Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications
Recent Patents on Cardiovascular Drug Discovery · 2006
DOI: 10.2174/157489006777442531 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Recent Patents on Cardiovascular Drug Discovery, 2006. Verfasst von Zia A Khan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pathology, University of Western Ontario, London, Canada. Die Arbeit wurde bisher 15-mal zitiert (Crossref).
Abstract (Originalsprache)
In an ever-increasing population of patients with diabetes, morbidity and mortality due to the secondary complications require prompt identification of the underlying mechanisms. Aberration in the vascular endothelial cell function may be a key element in the development and progression of the chronic diabetic complications. We present the hypothesis that preservation and restoration of the endothelial cell function may potentially be the most efficient means of targeting the adverse effects of hyperglycemia.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- Department of Pathology, University of Western Ontario, London, Canada.
Zitieren
APA
Khan, Z. A., & Chakrabarti, S. (2006). Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications. Recent Patents on Cardiovascular Drug Discovery. https://doi.org/10.2174/157489006777442531
Vancouver
Khan ZA, Chakrabarti S. Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications. Recent Patents on Cardiovascular Drug Discovery. 2006. doi:10.2174/157489006777442531
BibTeX
@article{Khan2006,
author = {Khan, Zia A and Chakrabarti, Subrata},
title = {Therapeutic Targeting of Endothelial Dysfunction in Chronic Diabetic Complications},
journal = {Recent Patents on Cardiovascular Drug Discovery},
year = {2006},
doi = {10.2174/157489006777442531}
}
EUVIMED